Filtered By:
Condition: Sickle Cell Anemia

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 1318 results found since Jan 2013.

Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study
CONCLUSION: There is a distinct subset of individuals with HbSC who developed overt, silent stroke, and cerebral vasculopathy. A female predominance and association with Rec VOCs were identified in our cohort; however, larger clinical trials are needed to identify and confirm specific clinical and laboratory markers associated with stroke and vasculopathy in HbSC disease.PMID:34749363 | DOI:10.1159/000519360
Source: Acta Haematologica - November 8, 2021 Category: Hematology Authors: Bindu Kanathezhath Sathi Yilin Yoshida Michael Raymond Weaver Lila S Nolan Barbara Gruner Vinod Balasa Talissa Altes Carlos Leiva-Salinas Source Type: research

Stroke in paediatric patients with sickle-cell anaemia.
CONCLUSIONS. Drepanocytosis is a disease that is emerging in our setting as a result of immigration. It should be suspected in cases of paediatric strokes associated to anaemia, above all in black children under the age of five who were not submitted to neonatal screening. PMID: 25059265 [PubMed - in process]
Source: Revista de Neurologia - July 29, 2014 Category: Neurology Authors: Diaz-Diaz J, Camacho-Salas A, Nunez-Enamorado N, Carro-Rodriguez MA, Sanchez-Galan V, Martinez de Aragon A, Simon-De Las Heras R Tags: Rev Neurol Source Type: research

20 years of Modifying Stroke Risk in Sickle Cell Disease (SCD) Patients: a Single Center Experience of Bone Marrow Transplant (BMT) in SCD (P6.256)
Conclusions:While BMT is curative for SCD, the impact on cerebral vasculopathy and ongoing stroke risk is unknown. Data from this sample suggests that BMT is associated with stabilization but not resolution of vasculopathy and dramatic reduction of stroke after the first year.Study Supported by:N/ADisclosure: Dr. Carpenter has nothing to disclose. Dr. Farias Moeller has nothing to disclose. Dr. Abraham has nothing to disclose. Dr. Khademian has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Carpenter, J., Moeller, R. F., Abraham, A., Khademian, Z. Tags: Non-Atherosclerotic Angiopathies and Cerebral Venous Thrombosis Source Type: research

Stroke Treatment in the Setting of Systemic Disease
AbstractWhile the possible stroke risks for more prevalent conditions, such as cardiac disease or cancer, are important to recognize, there are other equally devastating systemic diseases that can affect younger adults and, if not cautious, may be misdiagnosed if stroke is the initial presentation.Purpose of reviewWe aim to discuss treatments of three rarer, but important systemic diseases associated with an increased incidence of ischemic stroke, specifically sickle cell anemia, human immunodeficiency virus (HIV), and Takayasu ’s arteritis.Recent findingsGiven that individuals with these diseases are now living longer, ...
Source: Current Treatment Options in Neurology - November 13, 2020 Category: Neurology Source Type: research

Implementation of transcranial Doppler ultrasonography screening and primary stroke prevention in urban and rural sickle cell disease populations
ConclusionsWe report here data describing primary stroke prophylaxis in rural patients. SOC rates are similar between the two clinical settings. While implementation of primary stroke prevention in rural patients was difficult, rural TCD screening is feasible and can achieve SOC equal to that in an urban setting. This suggests that barriers exist in provided primary stroke prevention to all patients. Pediatr Blood Cancer © 2014 Wiley Periodicals, Inc.
Source: Pediatric Blood and Cancer - November 8, 2014 Category: Cancer & Oncology Authors: Samiya Hussain, Fenwick Nichols, Latanya Bowman, Hongyan Xu, Cindy Neunert Tags: Research Article Source Type: research

Stroke In Young Adults: A 4-Year Retrospective Hospital-Based Study, First Report From United Arab Emirates (P1.020)
CONCLUSIONS: Stroke in young adults is prevalent in our region; main cause is unknown. The increased mortality in this age population is alarming requiring better risk-factor control measures. MR: Mortality rates, ICH: intracerebral hemorrhage, SAH: subarachnoid hemorrhageDisclosure: Dr. AlAmeri has nothing to disclose. Dr. AlNuaimi has nothing to disclose. Dr. Alsaadi has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: AlAmeri, M., AlNuaimi, A., Alsaadi, T. Tags: Cerebrovascular Disease and Interventional Neurology I ePosters Source Type: research

Genetic determinants and stroke in children with sickle cell disease.
CONCLUSION: There is a high incidence of stroke in male children and in children with SCA. Coexistence with α-thal and haplotypes of the beta globin chain cluster did not show any significant association with stroke. The heterogeneity between previously evaluated populations, the non-reproducibility between studies, and the need to identify factors associated with stroke in patients with SCA indicate the necessity of conducting further research to demonstrate the relevance of genetic factors in stroke related to SCD. PMID: 27268459 [PubMed - as supplied by publisher]
Source: Jornal de Pediatria - June 3, 2016 Category: Pediatrics Authors: Rodrigues DO, Ribeiro LC, Sudário LC, Teixeira MT, Martins ML, Pittella AM, Junior IO Tags: J Pediatr (Rio J) Source Type: research

Interleukin-1 receptor inhibition reduces stroke size in a murine model of sickle cell disease.
Abstract Sickle cell disease (SCD) is associated with chronic hemolytic anemia and a heightened inflammatory state. The causal role of inflammatory pathways in stroke associated with SCD is unclear. Therefore, the hypothesis that deletion of the non-hematopoietic interleukin-1 receptor (IL-1R) pool may be beneficial in SCD was pursued. Since potential deleterious effects of IL-1R signaling in SCD could be mediated via downstream production of interleukin-6 (IL-6), the role of the non-hematopoietic IL-6 pool was also addressed. Bone marrow transplantation (BMT) from SCD to wild-type (WT) recipient mice was used to ...
Source: Haematologica - August 12, 2020 Category: Hematology Authors: Venugopal J, Wang J, Mawri J, Guo C, Eitzman D Tags: Haematologica Source Type: research

Advances in the Diagnosis and Treatment of Pediatric Arterial Ischemic Stroke
AbstractThough rare, stroke in infants and children is an important cause of mortality and chronic morbidity in the pediatric population. Neuroimaging advances and implementation of pediatric stroke care protocols have led to the ability to rapidly diagnose stroke and in many cases determine the stroke etiology. Though data on efficacy of hyperacute therapies, such as intravenous thrombolysis and mechanical thrombectomy, in pediatric stroke are limited, feasibility and safety data are mounting and support careful consideration of these treatments for childhood stroke. Recent therapeutic advances allow for targeted stroke p...
Source: Neurotherapeutics - April 18, 2023 Category: Neurology Source Type: research

β(S) globin gene haplotype and the stroke risk among Egyptian children with sickle cell disease.
CONCLUSION: This study provides a relevant contribution to our understanding of the anthropological and historical background of the population in Egypt where Benin haplotype is the commonest β(S) globin gene haplotype and homozygous Benin/Benin is associated with higher stroke risk than other haplotypes. PMID: 29157167 [PubMed - as supplied by publisher]
Source: Hematology - November 23, 2017 Category: Hematology Tags: Hematology Source Type: research

A Genetic Variant in GOLGB1 Affects Golgi Function and Stroke Risk in Patients with Sickle Cell Disease
Conclusions: Our study has shown that a coding variant in GOLGB1, identified as protective against risk of stroke in patients with SCD, has significant effects on Golgi function in SCD samples. We observed that having the GOLGB1 Y1212C variant resulted in more compact and less fragmented Golgi apparatus. Proteomic analysis showed that SCD patients with the GOLGB1 variant also had significantly lower levels of proteins involved in platelet activation and Golgi trafficking. Our findings suggest a novel role for the Golgi apparatus in controlling protein flux that modulates risk of stroke in SCD.DisclosuresNo relevant conflic...
Source: Blood - November 21, 2018 Category: Hematology Authors: Kotu, V., Dubrelle, J., Baker, J., Jenson, K., Flanagan, J. M. Tags: 113. Hemoglobinopathies, Excluding Thalassemia-Basic and Translational Science: Poster III Source Type: research

Risk factors and subtypes of ischemic stroke in young patients: an observational study from a teaching hospital in Saudi Arabia.
Authors: Shahid R Abstract Young adults are a key part of any society and the psychosocial and economic burden of any chronic or devastating disease in this particular group has significant consequences and impacts negatively on the development of the society as a whole. Although stroke in this age group is relatively rare, its consequences, in terms of lifelong dependence and disability, are substantial. Therefore, it is important to address this issue. In this retrospective epidemiological study, we analyzed the medical records of young patients (aged 18- 45 years) with a diagnosis of stroke during the study peri...
Source: Functional Neurology - September 28, 2019 Category: Neurology Tags: Funct Neurol Source Type: research

The role of hydroxyurea to prevent silent stroke in sickle cell disease: Systematic review and meta-analysis
Conclusion: Our findings suggest that hydroxyurea is safe and may prevent silent stroke and stroke in sickle cell disease. More high-quality studies including RCTs are needed.
Source: Medicine - December 1, 2019 Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research